AbbVie challenges 'outdated' 340B drug discount program guidance in new lawsuit
This image was generated by AI and may not depict real events.
AbbVie has filed a lawsuit against the US Department of Health and Human Services, challenging the definition of a 'patient' under the 340B drug discount program. The company claims the current definition is outdated and has created loopholes that allow covered entities to claim discounts improperly.
AbbVie is suing the US Department of Health and Human Services over the 340B drug discount program. The program requires drugmakers to provide discounts to eligible hospitals and clinics that serve low-income or uninsured patients. AbbVie claims the current definition of a 'patient' is outdated and has created loopholes. The company wants the court to authorize audits based on a new definition of 'patient'. This definition would require a person to have received recent and substantial medical care from a 340B eligible provider. AbbVie's lawsuit is part of a long-running fight to reform the 340B program.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.